Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.
Scalable whole-exome sequencing of cell-free DNA reveals high concordance with metastatic tumors.
复制标题
无细胞DNA的可扩展全外显子组测序显示与转移性肿瘤高度一致。
DOI:
10.1038/s41467-017-00965-y
复制
发表时间:
2017-11-06
影响因子:
16.6
通讯作者:
Meyerson M
中科院分区:
文献类型:
--
作者:
Adalsteinsson VA;Ha G;Freeman SS;Choudhury AD;Stover DG;Parsons HA;Gydush G;Reed SC;Rotem D;Rhoades J;Loginov D;Livitz D;Rosebrock D;Leshchiner I;Kim J;Stewart C;Rosenberg M;Francis JM;Zhang CZ;Cohen O;Oh C;Ding H;Polak P;Lloyd M;Mahmud S;Helvie K;Merrill MS;Santiago RA;O'Connor EP;Jeong SH;Leeson R;Barry RM;Kramkowski JF;Zhang Z;Polacek L;Lohr JG;Schleicher M;Lipscomb E;Saltzman A;Oliver NM;Marini L;Waks AG;Harshman LC;Tolaney SM;Van Allen EM;Winer EP;Lin NU;Nakabayashi M;Taplin ME;Johannessen CM;Garraway LA;Golub TR;Boehm JS;Wagle N;Getz G;Love JC;Meyerson M
Whole-exome sequencing of cell-free DNA (cfDNA) could enable comprehensive profiling of tumors from blood but the genome-wide concordance between cfDNA and tumor biopsies is uncertain. Here we report ichorCNA, software that quantifies tumor content in cfDNA from 0.1× coverage whole-genome sequencing data without prior knowledge of tumor mutations. We apply ichorCNA to 1439 blood samples from 520 patients with metastatic prostate or breast cancers. In the earliest tested sample for each patient, 34% of patients have ≥10% tumor-derived cfDNA, sufficient for standard coverage whole-exome sequencing. Using whole-exome sequencing, we validate the concordance of clonal somatic mutations (88%), copy number alterations (80%), mutational signatures, and neoantigens between cfDNA and matched tumor biopsies from 41 patients with ≥10% cfDNA tumor content. In summary, we provide methods to identify patients eligible for comprehensive cfDNA profiling, revealing its applicability to many patients, and demonstrate high concordance of cfDNA and metastatic tumor whole-exome sequencing. Identifying the mutational landscape of tumours from cell-free DNA in the blood could help diagnostics in cancer. Here, the authors present ichorCNA, software that quantifies tumour content in cell free DNA, and they demonstrate that cell-free DNA whole-exome sequencing is concordant with metastatic tumour whole-exome sequencing.
登录
查看更多内容
影响因子:
7
作者:
Ha G;Roth A;Lai D;Bashashati A;Ding J;Goya R;Giuliany R;Rosner J;Oloumi A;Shumansky K;Chin SF;Turashvili G;Hirst M;Caldas C;Marra MA;Aparicio S;Shah SP
通讯作者:
Shah SP
影响因子:
64.8
作者:
通讯作者:
--
影响因子:
7
作者:
Harrow J;Frankish A;Gonzalez JM;Tapanari E;Diekhans M;Kokocinski F;Aken BL;Barrell D;Zadissa A;Searle S;Barnes I;Bignell A;Boychenko V;Hunt T;Kay M;Mukherjee G;Rajan J;Despacio-Reyes G;Saunders G;Steward C;Harte R;Lin M;Howald C;Tanzer A;Derrien T;Chrast J;Walters N;Balasubramanian S;Pei B;Tress M;Rodriguez JM;Ezkurdia I;van Baren J;Brent M;Haussler D;Kellis M;Valencia A;Reymond A;Gerstein M;Guigó R;Hubbard TJ
通讯作者:
Hubbard TJ
影响因子:
7
作者:
Ha G;Roth A;Khattra J;Ho J;Yap D;Prentice LM;Melnyk N;McPherson A;Bashashati A;Laks E;Biele J;Ding J;Le A;Rosner J;Shumansky K;Marra MA;Gilks CB;Huntsman DG;McAlpine JN;Aparicio S;Shah SP
通讯作者:
Shah SP
影响因子:
64.8
作者:
Curtis, Christina;Shah, Sohrab P.;Chin, Suet-Feung;Turashvili, Gulisa;Rueda, Oscar M.;Dunning, Mark J.;Speed, Doug;Lynch, Andy G.;Samarajiwa, Shamith;Yuan, Yinyin;Graef, Stefan;Ha, Gavin;Haffari, Gholamreza;Bashashati, Ali;Russell, Roslin;McKinney, Steven;Langerod, Anita;Green, Andrew;Provenzano, Elena;Wishart, Gordon;Pinder, Sarah;Watson, Peter;Markowetz, Florian;Murphy, Leigh;Ellis, Ian;Purushotham, Arnie;Borresen-Dale, Anne-Lise;Brenton, James D.;Tavare, Simon;Caldas, Carlos;Aparicio, Samuel
通讯作者:
Aparicio, Samuel